Extrapyramidal side-effects.
D000818:Animals; D014150:Antipsychotic Agents / Q000633:toxicity; D001480:Basal Ganglia Diseases / Q000139:chemically induced* / Q000503:physiopathology; D002375:Catalepsy / Q000139:chemically induced; D004195:Disease Models, Animal; D004298:Dopamine / Q000502:physiology; D004353:Drug Evaluation, Preclinical; D004409:Dyskinesia, Drug-Induced / Q000209:etiology; D004421:Dystonia / Q000139:chemically induced; D006801:Humans; D010302:Parkinson Disease, Secondary / Q000139:chemically induced; D011954:Receptors, Dopamine / Q000187:drug effects
D014150:Antipsychotic Agents; D011954:Receptors, Dopamine; D004298:Dopamine